Search Within

Rachel Nicole Grisham

Formats
  1. Journal Article (80)
  2. Meeting Abstract (78)
  3. Review (9)
  4. Guidelines (3)
  5. Book Section (2)
  6. Editorial (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (175)
  2. GDMT, Medicine (175)
  3. Gynecologic Medicine Service (175)
  4. Gynecology Disease Management Team (175)
  5. Solid Tumor Oncology Division (175)
  6. Surgery (76)

More Groups

People
  1. Carol Aghajanian (87)
  2. Roisin O'Cearbhaill (68)
  3. Alexia Iasonos (63)
  4. Qin Zhou (56)
  5. Dennis Chi (52)
  6. Kara Long Roche (49)

More People

Years
  1. 2025 (13)
  2. 2024 (29)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Gynecologic Oncology (49)
  2. Journal of Clinical Oncology (37)
  3. International Journal of Gynecological Cancer (28)
  4. Clinical Cancer Research (8)
  5. Cancer (7)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. American Society of Clinical Oncology (42)
  3. Lippincott Williams & Wilkins (30)
  4. American Association for Cancer Research (10)
  5. Wiley Blackwell (8)
  6. Nature Publishing Group (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Kahn, R. M.; Boerner, T.; Kim, M.; Lam, C.; Gordhandas, S.; Yeoshoua, E.; Zhou, Q. C.; Iasonos, A.; Al-Niaimi, A.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer
    Journal Article

    Andres, S.; Finch, L.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Jang, D.; O'Cearbhaill, R.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
    Journal Article

    Manning-Geist, B. L.; Sullivan, M. W.; Zhou, Q.; Iasonos, A.; Selenica, P.; Stallworth, C.; Liu, Y.; Long Roche, K.; Gordhandas, S.; Aghajanian, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Redefining the standard of care for low-grade serous ovarian cancer
    Review

    Manning-Geist, B. L.; Cantor, T.; O'Cearbhaill, R. E.; Grisham, R. N.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Management challenges in low-grade serous ovarian cancer with a BRCA mutation
    Journal Article

    Sanchez-Lorenzo, L.; Sancho, L.; Iscar, T.; Grisham, R.; Chiva, L.
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
    Journal Article

    Ehmann, S.; Lam, C.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; Long Roche, K.; Zivanovic, O.; Sonoda, Y.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer
    Journal Article

    Boerner, T.; Lam, C.; Basaran, D.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Long Roche, K.; Zivanovic, O.; Abu-Rustum, N. R.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save